Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 358
7
Diseases
4
Unique genes
0.325
Avg. similarity score
Bilateral generalized polymicrogyria
Most-connected disease (5 links)
Disease
Searched: Neurodevelopmental disorder with or without hyperkinetic movements and seizures
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Neurodevelopmental disorder with or without hyperkinetic movements and seizures
Bilateral generalized polymicrogyria
Microcephalic primordial dwarfism
Microcephaly with or without short stature
Microcephaly, short stature, and polymicrogyria with seizures
Intellectual disability, autosomal dominant 8
Microcephaly, epilepsy, cerebral and/or cerebellar atrophy and short stature
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Bilateral generalized polymicrogyria | 5 | 5 | 2 |
| Microcephalic primordial dwarfism | 4 | 4 | 2 |
| Microcephaly with or without short stature | 3 | 3 | 2 |
| Microcephaly, short stature, and polymicrogyria with seizures | 3 | 3 | 1 |
| Intellectual disability, autosomal dominant 8 | 2 | 2 | 1 |
| Neurodevelopmental disorder with or without hyperkinetic movements and seizures | 2 | 2 | 1 |
| Microcephaly, epilepsy, cerebral and/or cerebellar atrophy and short stature | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| RTTN | 4 / 7 | Bilateral generalized polymicrogyria, Microcephalic primordial dwarfism, Microcephaly with or without short stature, Microcephaly, short stature, and polymicrogyria with seizures |
| GRIN1 | 3 / 7 | Bilateral generalized polymicrogyria, Intellectual disability, autosomal dominant 8, Neurodevelopmental disorder with or without hyperkinetic movements and seizures |
| ZNF335 | 2 / 7 | Microcephalic primordial dwarfism, Microcephaly, epilepsy, cerebral and/or cerebellar atrophy and short stature |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Assembly and cell surface presentation of NMDA receptors | Reactome | 1 / 6 | 500× | 2.00e-3 | 1.90e-2 ✓ sig. |
| Synaptic adhesion-like molecules | Reactome | 1 / 21 | 143× | 6.98e-3 | 4.53e-2 ✓ sig. |
| Unblocking of NMDA receptors, glutamate binding and activation | Reactome | 1 / 22 | 136× | 7.31e-3 | 4.67e-2 ✓ sig. |
| EPHB-mediated forward signaling | Reactome | 1 / 39 | 77.0× | 1.29e-2 | 6.62e-2 |
| Nicotine addiction | KEGG | 1 / 41 | 73.2× | 1.36e-2 | 6.85e-2 |
| Cocaine addiction | KEGG | 1 / 49 | 61.3× | 1.62e-2 | 7.59e-2 |
| Long-term potentiation | KEGG | 1 / 67 | 44.8× | 2.21e-2 | 9.09e-2 |
| Amphetamine addiction | KEGG | 1 / 69 | 43.5× | 2.28e-2 | 9.23e-2 |
| Loss of Nlp from mitotic centrosomes | Reactome | 1 / 70 | 42.9× | 2.31e-2 | 9.31e-2 |
| Loss of proteins required for interphase microtubule organization from the centrosome | Reactome | 1 / 70 | 42.9× | 2.31e-2 | 9.31e-2 |
| AURKA Activation by TPX2 | Reactome | 1 / 73 | 41.1× | 2.41e-2 | 9.55e-2 |
| Recruitment of mitotic centrosome proteins and complexes | Reactome | 1 / 82 | 36.6× | 2.70e-2 | 1.02e-1 |
| Regulation of PLK1 Activity at G2/M Transition | Reactome | 1 / 88 | 34.1× | 2.90e-2 | 1.06e-1 |
| Recruitment of NuMA to mitotic centrosomes | Reactome | 1 / 94 | 31.9× | 3.09e-2 | 1.10e-1 |
| Circadian entrainment | KEGG | 1 / 97 | 31.0× | 3.19e-2 | 1.12e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| centriole replication | GO:0007099 | 2 / 24 | 389× | 9.47e-6 | 5.21e-4 ✓ sig. |
| propylene metabolic process | GO:0018964 | 1 / 1 | 4,672× | 2.14e-4 | 5.31e-3 ✓ sig. |
| response to glycine | GO:1905429 | 1 / 1 | 4,672× | 2.14e-4 | 5.31e-3 ✓ sig. |
| brain development | GO:0007420 | 2 / 244 | 38.3× | 1.00e-3 | 1.46e-2 ✓ sig. |
| ciliary basal body organization | GO:0032053 | 1 / 5 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| de novo centriole assembly involved in multi-ciliated epithelial cell differentiation | GO:0098535 | 1 / 5 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| positive regulation of lymphocyte proliferation | GO:0050671 | 1 / 9 | 519× | 1.93e-3 | 2.07e-2 ✓ sig. |
| calcium ion transmembrane import into cytosol | GO:0097553 | 1 / 10 | 467× | 2.14e-3 | 2.19e-2 ✓ sig. |
| regulation of monoatomic cation transmembrane transport | GO:1904062 | 1 / 10 | 467× | 2.14e-3 | 2.19e-2 ✓ sig. |
| centriole-centriole cohesion | GO:0010457 | 1 / 13 | 359× | 2.78e-3 | 2.51e-2 ✓ sig. |
| excitatory chemical synaptic transmission | GO:0098976 | 1 / 13 | 359× | 2.78e-3 | 2.51e-2 ✓ sig. |
| positive regulation of calcium ion transport into cytosol | GO:0010524 | 1 / 14 | 334× | 2.99e-3 | 2.59e-2 ✓ sig. |
| protein heterotetramerization | GO:0051290 | 1 / 16 | 292× | 3.42e-3 | 2.78e-2 ✓ sig. |
| cerebral cortex neuron differentiation | GO:0021895 | 1 / 16 | 292× | 3.42e-3 | 2.78e-2 ✓ sig. |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 1 / 17 | 275× | 3.63e-3 | 2.86e-2 ✓ sig. |